Medicine recalls
|
| |
| Batch recall of Augmentin Powder for Syrup 457mg/5ml |
| |
The Department of Health (DH) today (30 August) endorsed a licensed drug wholesaler, namely GlaxoSmithKline Ltd (GSK), to recall one batch (batch number: HU7J) of Augmentin Powder for Syrup 457mg/5ml (Hong Kong Registration number: HK-42735), from the market as a precautionary measure due to potential quality issue.
The DH received notification from GSK that the its overseas headquarters has initiated product recall of the above batch due to the potential issue that some of the containers may have an ineffective seal which could lead to humidity exposure and discoloration of the product. As a precautionary measure, GSK is voluntarily recalling the above batch from the market.
The above product, containing amoxicillin and clavulanic acid, is an antibiotic used for the treatment of bacterial infection. According to GSK, the above batch of product have been imported into Hong Kong for distribution to the local private hospitals, private doctors and pharmacies, as well as for re-export to Macao.
GSK has set up a hotline (3622 5422) to answer related enquiries.
So far, the DH has not received any adverse reaction reports in connection with the above batch of product. The DH will closely monitor the recall.
Patients who are taking the above batch of product should not stop taking the medicine, but should consult their healthcare professionals as soon as possible for appropriate arrangements.
Ends/Friday, Aug 30, 2024
|
| |
|
